Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Researchers conducted a phase 3b randomized study of a cohort in the VISIBLE trial, which included 103 adults with skin of color and moderate-to-severe psoriasis (mean age, 44.1 years; 28.2% women ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

A recently published analysis that appeared in the Journal of American Academy of Dermatology has concluded that the general percentage of adults in ...

The company said that the trials (double-blind, placebo-controlled Phase 2 trial evaluated the efficacy and safety) were conducted in 263 patients with moderate to severe plaque psoriasis.

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

Turmeric and ginger are antioxidant powerhouses—but which is stronger? Discover benefits, side effects, and whether you can ...

Eli Lilly and Company, Pfizer, Merck & Co., Inc., AbbVie, and Thermo Fisher Scientific are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical ...

Magnesium oil applied to the feet may have some beneficial effects for certain health issues, including psoriasis and foot ...

Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections i ...

Each of these soft gels contains 30 mg of broad-spectrum CBD. They are flavor-free and contain hemp extract, MCT from coconut, and a gelatin and glycerin shell. The company recommends taking 1 to ...